These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8885131)

  • 1. Tumour dormancy and cell signalling--III: Role of hypercrosslinking of IgM and CD40 on the induction of cell cycle arrest and apoptosis in B lymphoma cells.
    Marches R; Racila E; Tucker TF; Picker L; Mongini P; Hsueh R; Vitetta ES; Scheuermann RH; Uhr JW
    Ther Immunol; 1995 Jun; 2(3):125-36. PubMed ID: 8885131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction.
    Merino R; Grillot DA; Simonian PL; Muthukkumar S; Fanslow WC; Bondada S; Núñez G
    J Immunol; 1995 Oct; 155(8):3830-8. PubMed ID: 7561089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest.
    Santos-Argumedo L; Gordon J; Heath AW; Howard M
    Cell Immunol; 1994 Jul; 156(2):272-85. PubMed ID: 7517793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulatory effects of cAMP-elevating agents on human normal and neoplastic B cell functional response following ligation of surface immunoglobulin and CD40.
    Kelly K; Knox KA
    Cell Immunol; 1995 Nov; 166(1):93-102. PubMed ID: 7585986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line.
    Lee JR; Koretzky GA
    J Immunol; 1998 Aug; 161(4):1637-44. PubMed ID: 9712025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL.
    Yi AK; Hornbeck P; Lafrenz DE; Krieg AM
    J Immunol; 1996 Dec; 157(11):4918-25. PubMed ID: 8943396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer dormancy: lessons from a B cell lymphoma and adenocarcinoma of the prostate.
    Rabinovsky R; Uhr JW; Vitetta ES; Yefenof E
    Adv Cancer Res; 2007; 97():189-202. PubMed ID: 17419946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM.
    Lin CK; Nguyen TT; Morgan TL; Mei RL; Kaptein JS; Kalunta CI; Yen CF; Park E; Zou HY; Lad PM
    Exp Cell Res; 1998 Oct; 244(1):1-13. PubMed ID: 9770343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40.
    Law CL; Gordon KA; Collier J; Klussman K; McEarchern JA; Cerveny CG; Mixan BJ; Lee WP; Lin Z; Valdez P; Wahl AF; Grewal IS
    Cancer Res; 2005 Sep; 65(18):8331-8. PubMed ID: 16166310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
    Walker A; Taylor ST; Hickman JA; Dive C
    Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells.
    Honeychurch J; Glennie MJ; Illidge TM
    Cancer Res; 2005 Aug; 65(16):7493-501. PubMed ID: 16103104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer dormancy. VII. A regulatory role for CD8+ T cells and IFN-gamma in establishing and maintaining the tumor-dormant state.
    Farrar JD; Katz KH; Windsor J; Thrush G; Scheuermann RH; Uhr JW; Street NE
    J Immunol; 1999 Mar; 162(5):2842-9. PubMed ID: 10072532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice.
    Racila E; Scheuermann RH; Picker LJ; Yefenof E; Tucker T; Chang W; Marches R; Street NE; Vitetta ES; Uhr JW
    J Exp Med; 1995 Apr; 181(4):1539-50. PubMed ID: 7535341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells.
    Cragg MS; Zhang L; French RR; Glennie MJ
    Br J Cancer; 1999 Feb; 79(5-6):850-7. PubMed ID: 10070880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dormancy in a model of murine B cell lymphoma.
    Uhr JW; Marches R
    Semin Cancer Biol; 2001 Aug; 11(4):277-83. PubMed ID: 11513563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization of multiple myeloma and B lymphoma lines to dexamethasone and gamma-radiation-induced apoptosis by CD40 activation.
    Zhou ZH; Shi Q; Wang JF; Chen YJ; Zhuang YM; Pan JZ; Xu CS; Qi CJ; Zhang XG
    Apoptosis; 2005 Jan; 10(1):123-34. PubMed ID: 15711928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant signals leading to inhibitor kappaB protein degradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis.
    Schauer SL; Bellas RE; Sonenshein GE
    J Immunol; 1998 May; 160(9):4398-405. PubMed ID: 9574544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha inhibits anti-IgM-mediated apoptosis in Ramos cells.
    Park E; Kalunta CI; Nguyen TT; Wang CL; Chen FS; Lin CK; Kaptein JS; Lad PM
    Exp Cell Res; 1996 Jul; 226(1):1-10. PubMed ID: 8660933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel tetravalent anti-CD20 antibodies with potent antitumor activity.
    Li B; Shi S; Qian W; Zhao L; Zhang D; Hou S; Zheng L; Dai J; Zhao J; Wang H; Guo Y
    Cancer Res; 2008 Apr; 68(7):2400-8. PubMed ID: 18381448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to murine CD40 define two distinct functional epitopes.
    Heath AW; Wu WW; Howard MC
    Eur J Immunol; 1994 Aug; 24(8):1828-34. PubMed ID: 7519997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.